These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9231310)

  • 1. Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series.
    Findling RL
    J Child Adolesc Psychopharmacol; 1996; 6(3):165-75. PubMed ID: 9231310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance to fluoxetine.
    Rapport DJ; Calabrese JR
    J Clin Psychopharmacol; 1993 Oct; 13(5):361. PubMed ID: 8227494
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline.
    Thase ME; Blomgren SL; Birkett MA; Apter JT; Tepner RG
    J Clin Psychiatry; 1997 Jan; 58(1):16-21. PubMed ID: 9055832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sertraline for body dysmorphic disorder.
    el-Khatib HE; Dickey TO
    J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1404-5. PubMed ID: 8543506
    [No Abstract]   [Full Text] [Related]  

  • 5. Does intolerance or lack of response with fluoxetine predict the same will happen with sertraline?
    Zarate CA; Kando JC; Tohen M; Weiss MK; Cole JO
    J Clin Psychiatry; 1996 Feb; 57(2):67-71. PubMed ID: 8591971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are patients who are intolerant to one SSRI intolerant to another?
    Brown WA; Harrison W
    Psychopharmacol Bull; 1992; 28(3):253-6. PubMed ID: 1480728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another?
    Brown WA; Harrison W
    J Clin Psychiatry; 1995 Jan; 56(1):30-4. PubMed ID: 7836337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitor dose titration in the naturalistic setting.
    Gregor KJ; Overhage JM; Coons SJ; McDonald RC
    Clin Ther; 1994; 16(2):306-15; discussion 271-2. PubMed ID: 8062324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression.
    Aguglia E; Casacchia M; Cassano GB; Faravelli C; Ferrari G; Giordano P; Pancheri P; Ravizza L; Trabucchi M; Bolino F
    Int Clin Psychopharmacol; 1993; 8(3):197-202. PubMed ID: 8263318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression.
    Bennie EH; Mullin JM; Martindale JJ
    J Clin Psychiatry; 1995 Jun; 56(6):229-37. PubMed ID: 7775364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.
    Bodkin JA; Lasser RA; Wines JD; Gardner DM; Baldessarini RJ
    J Clin Psychiatry; 1997 Apr; 58(4):137-45. PubMed ID: 9164423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of response to serotonin reuptake inhibitors.
    Goldberg JF; Sacks MH; Kocsis JH
    Am J Psychiatry; 1995 Jun; 152(6):954. PubMed ID: 7755133
    [No Abstract]   [Full Text] [Related]  

  • 13. Depression: making the diagnosis and using SSRIs in the older patient.
    Reynolds CF
    Geriatrics; 1996 Oct; 51(10):28-34. PubMed ID: 8863755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sertraline with methylphenidate in an ICU patient.
    McGlohn SE; Bostwick JM
    Psychosomatics; 1995; 36(6):584-5. PubMed ID: 7501791
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphocyte subsets associated with major depression and dysthymia: modification by antidepressant treatment.
    Ravindran AV; Griffiths J; Merali Z; Anisman H
    Psychosom Med; 1995; 57(6):555-63. PubMed ID: 8600482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SSRI optimal dose remains at issue.
    Rifkin A
    J Clin Psychiatry; 1997 Feb; 58(2):87-8. PubMed ID: 9062381
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline.
    Preskorn S
    Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():13-9. PubMed ID: 7963446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination treatment with noradrenalin and serotonin reuptake inhibitors in resistant depression.
    Seth R; Jennings AL; Bindman J; Phillips J; Bergmann K
    Br J Psychiatry; 1992 Oct; 161():562-5. PubMed ID: 1327396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression.
    Zanardi R; Franchini L; Gasperini M; Perez J; Smeraldi E
    Am J Psychiatry; 1996 Dec; 153(12):1631-3. PubMed ID: 8942464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylphenidate augmentation of serotonin selective reuptake inhibitors: a case series.
    Stoll AL; Pillay SS; Diamond L; Workum SB; Cole JO
    J Clin Psychiatry; 1996 Feb; 57(2):72-6. PubMed ID: 8591972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.